Other languages Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Market Closed - NSE India S.E. Other stock markets 12:43:50 02/05/2024 BST			5-day change	1st Jan Change
988 ^INR	+3.61%		+2.98%	+43.35%

04-26	Weak March Quarter Earnings Weigh Down Indian Equities on Friday	MT
04-26	Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Weak March Quarter Earnings Weigh Down Indian Equities on Friday	04-26
Zydus Lifesciences Gets US FDA's Final Approval for Generic Acne Cream	04-26
Zydus Lifesciences Gets 10 Observations from US FDA After Jarod, India Manufacturing Site Inspection	04-24
Zydus Lifesciences Limited Announces New Drug Application of Zydus' Innovative Drug Desidustat Tablets by China Medical System Holdings Limited Accepted in China	04-23
Zydus Lifesciences Limited Launches Mirabegron Extended-Release Tablets in the U.S	04-22
Zydus Receives Approval from WHO International Non-Proprietary Names for Usnoflast as Recommended Name for ZYIL1	04-01
Zydus Gets Four Observations from US FDA for Oncology Injectable Plant	03-28
Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Letermovir Tablets, 240 Mg and 480 Mg	03-23
Zydus Lifesciences Gets US FDA's Final Nod for Finasteride and Tadalafil Capsules	03-18
Zydus Lifesciences Limited Receives Final Approval from USFDA and 180 Days CGT Exclusivity for Finasteride and Tadalafil Cap Capsules	03-16
Zydus Lifesciences Gets US FDA Final Nod for Chlorpromazine Hydrochloride Injection; Shares Jump 3%	03-14
Zydus Receives Final Approval from the USFDA for Chlorpromazine Hydrochloride Injection USP, 25 mg/mL and 50 mg/2 mL (25 mg/mL), Single-Dose Vials	03-14
Zydus Receives Tentative Approval from the USFDA for Edaravone Injection, 30 mg/100 mL (0.3 mg/mL), Single-Dose Vial	03-14
Zydus Lifesciences Launches Generic Cancer Drug Ibyra in India	03-13
Zydus Lifesciences Limited Launches IBYRA, the Generic Version of Olaparib	03-13
Zydus Lifesciences Gets US FDA's EIR for Ahmedabad, India Unit's Inspection	03-11
EXCLUSIVA-Eli Lilly podría lanzar un fármaco contra la obesidad en India el próximo año: presidente ejecutivo	02-28
Zydus Lifesciences Forms UAE-Based Arm	02-23
Zydus Lifesciences Limited Announces Incorporation of Wholly Owned Subsidiary Company	02-22
Zydus Lifesciences Gets US FDA Final Approval for Generic Chest Pain Drug	02-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zydus Lifesciences Limited

Equities

ZYDUSLIFE

INE010B01027

Other languages

Filters